Drug intelligence / Profile preview

Qushi Jiedu Formula

Development stage: Unknown
Lead developer: Guangzhou University of Chinese Medicine
Administration: Oral

Overview

Qushi Jiedu Formula is a Traditional Chinese Medicine (TCM) formula being investigated in a multi-center, double-blinded, randomized, placebo-controlled clinical trial for its effect on disease-free survival in patients with Stage II/III colon cancer after adjuvant chemotherapy. The name "Qushi Jiedu" in Traditional Chinese Medicine typically refers to functions of eliminating dampness and detoxification. It is administered orally.

Beyond the preview

Go deeper on Qushi Jiedu Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qushi Jiedu Formula.

Explore the full profile